Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Cataract and Refractive Surgery|April 30, 2002
Subclinical inflammation after laser in situ keratomileusis in corneal graftsHatice Nida Sen, Risto Uusitalo, Leila LaatikainenJournal of Ophthalmic Inflammation and Infection|March 22, 2013
A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patientWendy M Smith, Gary Fahle, Robert B Nussenblatt, et al.Current Eye Research|July 3, 2014
Gender disparities in ocular inflammatory disordersHatice Nida Sen, Janet Davis, Didar Ucar, et al.Research Square|June 6, 2022
Ocular Symptoms In COVID-19 Infection: A Survey StudyMatthew McHarg, Yujuan Wang, Mehmet Yakin, et al.Ocular Immunology and Inflammation|February 15, 2020
Optical Coherence Tomography Angiography Changes in Choroidal Vasculature following Treatment in Punctate Inner ChoroidopathyIan Abban Thompson, Sonny Caplash, Marib Akanda, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 4, 2017
Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 LevelsDavid E Kuo, Maggie M Wei, Karen R Armbrust, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2010
Fundus autofluorescence imaging of the white dot syndromesSteven Yeh, Farzin Forooghian, Wai T Wong, et al.Journal of Autoimmunity|June 24, 2008
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitisSteven Yeh, Keith Wroblewski, Ronald Buggage, et al.Journal of Autoimmunity|November 6, 2003
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administrationRobert B Nussenblatt, Darby J S Thompson, Zhuqing Li, et al.BMJ Oncology|January 31, 2025
Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.Pageof 1